stoxline Quote Chart Rank Option Currency Glossary
  
Colfax Corporation (CFX)
39.06  -1.53 (-3.77%)    04-05 00:00
Open: 40.6
High: 40.67
Volume: 2,953,345
  
Pre. Close: 40.59
Low: 38.88
Market Cap: 2,122(M)
Technical analysis
2022-11-18 4:19:24 PM
Short term     
Mid term     
Targets 6-month :  46.7 1-year :  47.5
Resists First :  39.98 Second :  40.66
Pivot price 39.06
Supports First :  38.88 Second :  32.34
MAs MA(5) :  39.06 MA(20) :  39.06
MA(100) :  39.06 MA(250) :  55.37
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  10 D(3) :  10
RSI RSI(14): 20.7
52-week High :  84.82 Low :  38.88
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CFX ] has closed Bollinger Bands are 0% narrower than normal.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 40.71 - 40.91 40.91 - 41.08
Low: 38.42 - 38.64 38.64 - 38.83
Close: 38.73 - 39.07 39.07 - 39.37
Company Description

Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Wilmington, Delaware.

Headline News

Sat, 16 Mar 2024
Colfax's (CFX) Unit Closes Buyout of Trilliant Surgical - Yahoo Movies Canada

Tue, 05 Apr 2022
Colfax Stock: Chapter Ends, ESAB & Enovis Have To Prove (NYSE:CFX) - Seeking Alpha

Mon, 14 Mar 2022
Colfax Announces Expected Completion Date of April 4, 2022 for Spin-Off of ESAB Corporation - Yahoo Finance

Fri, 11 Mar 2022
Colfax Announces Board of Directors for Enovis, the Post-Spinoff Medical Technology Company - Yahoo Finance

Thu, 10 Feb 2022
(02/10/22) Colfax: A Spinoff Bet on the Rales Brothers - Moneyshow.com

Fri, 17 Sep 2021
Hedge Fund and Insider Trading News: Ray Dalio, Steve Cohen, Dmitry Balyasny, Mike Rockefeller, EJF Capital ... - Insider Monkey

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Industrials
Industry:
Specialty Industrial Machinery
Shares Out 155 (M)
Shares Float 138 (M)
Held by Insiders 11.1 (%)
Held by Institutions 97.5 (%)
Shares Short 8,670 (K)
Shares Short P.Month 8,130 (K)
Stock Financials
EPS 0.7
EPS Est Next Qtrly 0.51
EPS Est This Year 1.72
EPS Est Next Year 1.96
Book Value (p.s.) 29.62
Profit Margin 2.9 %
Operating Margin 8.7 %
Return on Assets (ttm) 2.6 %
Return on Equity (ttm) 3.1 %
Qtrly Rev. Growth 19.7 %
Gross Profit (p.s.) 8.33
Sales Per Share 23.64
EBITDA (p.s.) 3.74
Qtrly Earnings Growth 65.5 %
Operating Cash Flow 389 (M)
Levered Free Cash Flow 210 (M)
Stock Valuations
PE Ratio 55.01
PEG Ratio 0.8
Price to Book value 1.31
Price to Sales 1.65
Price to Cash Flow 15.55
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android